Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Hepatocellular 12Neoplasm Metastasis 3Liver Neoplasms 3Leiomyoma 3Uveal Melanoma 2Spinal Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pelvic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Colorectal Neoplasms 1Colorectal Cancer Liver Metastases (CRLM) 1Colonic Neoplasms 1Chylous Ascites 1Blood Loss, Surgical 1Abdominal Neoplasms 1

Interventions

Surgical Procedures, Operative 1Sevoflurane 1Ropivacaine 1Propofol 1Paclitaxel 1Nitrous Oxide 1Lidocaine 1Iohexol 1Imatinib Mesylate 1Glycopyrrolate 1Food, Formulated 1Fluorouracil 1FS 069 1Enoxaparin 1Embolization, Therapeutic 1Doxorubicin 1Dietary Supplements 1Dexmedetomidine 1Cytoreduction Surgical Procedures 1Continuous Positive Airway Pressure 1Cisplatin 1Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Abdominal Neoplasms × Embolization, Therapeutic × Clear all
NCT06820320 2026-03-06

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed
42 enrolled
Gynecologic

Abdominal Neoplasms, Chylous Ascites, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡